Skip to main content

03-06-2020 | EULAR 2020 | Conference coverage | Video

Researcher comment: TNF inhibitors linked to reduced VTE risk in RA patients

Anja Strangfeld discusses an analysis of the German RABBIT registry comparing the risk for venous thromboembolism among patients with rheumatoid arthritis treated with different classes of medication (5:20).

Read the transcript

Related content

21-08-2019 | Tofacitinib | Feature | Article

Tofacitinib black box warning: A cause for concern?

How FDA alert about pulmonary embolism will affect rheumatoid arthritis treatment decisions